ABSTRACT-The effects of nilvadipine, a dihydropyridine type calcium channel blocker, on cerebral infarction induced by focal brain ischemia was studied in rats. The area of infarction was measured 24 hr after occlusion of the middle cerebral artery (MCA) in spontaneously hypertensive rats using triphenyltetrazolium chloride. Nilvadipine, given immediately after MCA occlusion, reduced the area of infarction significantly at doses of 0.32 mg/kg (i.p.) and 3.2, 10 and 32 mg/kg (p.o.). Nicardi pine suppressed the area of infarction at a dose of 32 mg/kg (p.o.). The results sug gest that nilvadipine is effective against ischemic brain injury.
Ischemic cerebrovascular disease remains the most prevalent neurologic disorder. Cal cium channel blockers have received attention as possible neuroprotective agents in ischemia both because of their potent cerebral vasodila tory activity (1, 2) and because they may pro tect neurons by preventing the accumulation of intracellular calcium (3, 4) which may serve as a trigger of irreversible cellular injury (5, 6) . Transient occlusion of the middle cerebral artery (MCA) has been reported to cause brain calcium accumulation (7) , and calcium channel blockers might therefore be expected to reduce the resulting ischemic injuries in the brain.
Nilvadipine, a novel dihydropyridine-type calcium channel blocker, has selective and long lasting effects on cerebral arteries (1) . It has also been reported that nilvadipine ex hibits a wide distribution into various tissues including the brain (8) . However, in general pharmacological tests, nilvadipine caused few effects on the central nervous system; for ex ample, it had no activity on the general be havior in conscious dogs (T. Ono et al., un published data). These results prompted us to study the effect of nilvadipine on experimental cerebral infarction in rats. In this study, we examined the effects of nilvadipine on the size of the infarction in the MCA occluded rat. MCA occlusion in SHR has been reported to be the most efficient for the production of large and uniform infarction (9) , and this strain was used in the present study.
Spontaneously hypertensive male rats (SHR), weighing 230 to 310 g, obtained from Charles River, were used. Anesthesia was in duced with inhalation of 4% halothane and maintained with 2% halothane in oxygen. The method of left MCA occlusion has been de scribed by Shiino et al. (9) . The left infra temporal fossa of the rat lying in the right lateral position was reached transorbitally. Us ing an operating microscope, a small craniec tomy, ca 2.5 mm in diameter, was made, and the left MCA was exposed. It was occluded with a bipolar coagulator and was also tran sected at the lateral margin of the olfactory tract. Drugs were given orally (p.o.) or in traperitoneally (i.p.), immediately after MCA occlusion. The total duration of anesthesia and operation did not exceed 20 min. Nilvadipine was prepared in our laboratories and nicardi pine hydrochloride (nicardipine) was obtained from Sigma. They were dissolved in poly ethyleneglycol 400 (PEG 400). Rats in the con trol group were injected with PEG 400. The area of infarction was determined 24 hr after MCA occlusion (10) . Rats were sacri ficed by decapitation, and the brain was quick ly removed. To determine a presumptive size of infarction, several serial coronal slices, 2 mm in thickness, were perpared both anterior ly and posteriorly to the bregma. Brain slices were incubated in 2% TIC solution at 37°C for 40 min. Photographs of the slices were then taken. For each slice, the area of infarc tion was measured, and the ratio (%) of the area of infarction to the whole area of the cor responding cerebral hemisphere was calculated using a computerized image analysis system. The data were expressed as the mean ± stan dard error (S.E.) and analyzed with Dunnett's type multiple comparisons. Table 1 . Effects of nilvadipine and nicardipine on ischemic brain injury after MCA occlusion in rats Figure 1 shows a typical example of cerebral infarction in this study at 4 mm posterior to the bregma (B 4). Infarction was found in the cerebral cortex and rarely extended into subcortical tissue. The area of infarction was almost always largest in the slice through the bregma in all groups (Table 1) and was gradu ally reduced as the distance from the bregma increased. The effects of nilvadipine and nicar dipine on the area of infarction is shown in Table 1 . Both drugs reduced the area of in farction in a dose-related fashion at each site. Nilvadipine, at doses of 3.2 mg/kg, p.o. and higher, significantly reduced the area of infarc tion at several sites. Nilvadipine in a dose of 0.32 mg/kg, i.p. also reduced the area of in farction significantly at the bregma and at posterior sites. Nicardipine also reduced the area of infarction; however, a higher dose was required than nilvadipine. The effects of nilva dipine on cerebral arteries are more selective and long-lasting than those of nicardipine (1).
Nilvadipine has been reported to be distrib uted well into the brain (8) , whereas the dis tribution of nicardipine into the brain might be less effective because of its water-solubility (11) . Brain concentrations of nilvadipine are indeed much higher than those of nicardipine after administration of equivalent doses (T. Fujiwara et al., unpublished data). These dif ferences may explain the differences of po tencies between nilvadipine and nicardipine. Calcium has been proposed as a trigger of ischemic cell death (5, 6) . The neuroprotective effect of drugs tested in this study may there fore reflect not only their vasodilatory effects, but also their ability to inhibit calcium influx.
The MCA occlusion model in rats has been widely used to evaluate the effect of some types of drugs (10, (12) (13) (14) . Reduction of the size of infarction may be the most important and fundamental of brain protective effects of drugs against cerebral ischemia. In conclusion, nilvadipine seems to be more potent than nicardipine and may be more effective as a neuroprotective agent in animal models of foc al cerebral ischemia.
